Skip to main content

Medical Marijuana Market to Rise at a Stellar 20.04% CAGR and Touch USD 26,920.4 Million by 2026; Growing cultivation and production Activities in Legalized States Will Bolster Growth, reports Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, Oct. 09, 2020 (GLOBE NEWSWIRE) — The global medical marijuana market size is expected to reach USD 26,920.4 million by 2026, owing to the increasing demand for decriminalization of marijuana in most parts of the world. Medical cannabis or medical marijuana is extracted from the marijuana plant and can be used for treating certain illnesses and health conditions. But due to government restrictions, the use of marijuana as a medicinal drug is not tested rigorously.According to this report, the market was USD 6,338.1 million in 2018 and is anticipated to exhibit a CAGR of 20.4% during the forecast period set between 2019 to 2026.
What is the Scope of the Report?The report is based on a thorough analysis of the market taking into account parameters such as growth drivers, restraints, current medical marijuana market trends, challenges, and opportunities that lies ahead of the market. It also discusses the market in details based on factors such as application, type, distribution channel, and geography.It also throws light on the competitive landscape of the market, names of significant players and the key strategies adopted by them to gain a competitive edge in the market. Furthermore, the report emphasizes on major industry developments, and other interesting insights into the market. The report is available for sale on the company website.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-marijuana-market-102609
Key Industry Developments of the Medical Marijuana Market Include:September 2019 – The first ever medical marijuana tablets were launched by Curaleaf in Florida and is available across 26 Curaleaf dispensaries across the U.S.March 2019 – Harvest One Cannabis signed an agreement with Health House for distributing Satipharm CBD Gelpell Capsules for carrying out business across Asia, New Zealand, and Australia.
Medicinal Properties of Cannabis to Propel GrowthThe increasing demand for legalization of medical cannabis across various states is a major medical marijuana market growth driver. Besides this, the rising prevalence of diseases such as Parkinson’s disease, cancer, neurological disorders, and acute pain diseases is also expected to aid in expansion of the market in the forecast period.On the contrary, increasing application of marijuana beyond the required dose may result in side effects such as hallucinations, dizziness, low blood pressure, and others. This may stand as a major challenge to the market in the long run.The global economy is in absolute turmoil because of the COVID-19 pandemic outbreak. Some industries remain largely unaffected by the outbreak, some are thriving, but most are in doldrums. Although the healthcare industry is flourishing, certain markets within the industry are experiencing staggered growth. Wading through these troubled times is a difficult task and Fortune Business Insights™ aims at equipping your business with the most comprehensive market insights, collated and analyzed by our expert and experienced research team.
Click here to get the short-term and long-term impact of COVID-19 on this market.Please visit: https://www.fortunebusinessinsights.com/medical-marijuana-market-102609
Increasing Awareness on medicinal Properties of Cannabis to Offer Lucrative Growth Opportunities for the Rest of the WorldGeographically, North America earned the maximum medical marijuana market share with a revenue of USD 5,994.9 million earned in 2018, that is anticipated to reach USD 24,578.3 million by the end of 2026.Growth of this region is attributed to the rise in the number of legalization of marijuana for both medical and recreational purposes, coupled with the presence of major vendors in the region. Europe ranks second in terms of cannabis cultivation and is expected to witness significant growth owing to the increasing investments for research activities by many public and private entities in the forthcoming years.Furthermore, the market in Latin America and the Rest of the World is anticipated to witness lucrative business opportunities in the years to follow. This is owing to the rise in prevalence of chronic ailments, psychiatric disorders, acute pain diseases and the increasing awareness about the medicinal benefits of cannabis.
Quick Buy –  Medical Marijuana Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102609
Entry of New Players will Intensify Market CompetitionThe rapid developmental pace of medical marijuana and its wide expansion has propelled many players to enter into this market and make heavy investments in research and development of the same. Although the most crucial part is its production and cultivation, significant medical marijuana market revenue is derived from the pharmacological organizations.Besides this, with the increasing number of marijuana legalization in various states, more and more players are entering into the market to make their mark in the competition. Existing players are focusing on geographical expansion for gaining a competitive edge in the market in the forthcoming years.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/medical-marijuana-market-102609
List of Medical Marijuana Market Manufacturers include:Aurora CannabisCannTrust HoldingsMedReleaf CorpEmerald Health TherapeuticsThe Cronos GroupGreen Relief Inc.Medical Marijuana, Inc.ABcann Medicinals, Inc.GW PharmaceuticalsAphria Inc.Canopy Growth CorporationOther Vendors
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/medical-marijuana-market-102609
Global Medical Marijuana Market Segmentations:By Application•              Pain Disorders•              Cancer•              OthersBy Type•              Flowers•              Concentrates•              Edibles•              OthersBy Distribution Channel•              Dispensaries•              Online channel•              OthersBy Geography•              North America (the U.S. and Canada)•              Europe (Germany, Belgium, France, Italy, and the Rest of Europe)•              Latin America (Mexico, Argentina, Brazil, and the Rest of Latin America)•              The Rest of the World (Row)
Have a Look at Related Reports:Pressure Ulcer Treatment Market Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026Stomach Cancer/Gastric Cancer Treatment Market Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2026Deep Brain Stimulation (DBS) Devices Market Share & Industry Analysis, By Product Type (Dual Channel Deep Brain stimulators, Single Channel Deep Brain Stimulators), By Application (Parkinson’s Disease, Dystonia, Essential Tremor, Others), By End User (Hospitals, Specialty Clinics, Others) and Regional Forecast, 2019-2026Biomarkers Market Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026Neuroendoscopy Devices Market Share & Industry Analysis, By Product Type (Rigid Neuroendoscopes, Flexible Neuroendoscopes), By Application Type (Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, Transcranial Neuroendoscopy), By End User (Hospitals, Specialty Clinics, Others) and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/medical-marijuana-market-9746

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.